SEOUL,South Korea,Nov. 15,2024-- Nuvilab announced that its innovative AI nutrition coaching solution,NutriTrex,was awarded the CES 2025 Innovation Award in the Digital Health category. This prestigio
JAKARTA,Indonesia,Nov. 15,2024-- Doo Group\'s brokerage brand,Doo Financial is thrilled to announce its expansion into Indonesia by acquiring a reputable Indonesian broker to expand the business. This
GUIYANG,China,Nov. 15,2024-- A report byHuanqiu.com
Guiyang,a city where profound history and modern civilization perfectly blend,is drawing the world\'s attention with its unique charm. The city is i
BEIJING,Nov. 18,2024-- Brazil officially assumed the one-year presidency of the G20 in December 2023,with the motto "Building a just world and a sustainable planet." This aligns with the com
MANILA,Philippines,Nov. 18,2024--Salmon,the fintech leader driving financial inclusion in Southeast Asia,has been recognized as theLeading Fintech Group Philippinesat the esteemed World Business Outlo
TOKYO and SEOUL,South Korea,Nov. 18,2024-- On the 18th,MINISH Technology Inc. announced it will host a "Special Course for Japanese Dentists" at MINISH Dental Hospital in Gangnam,Seoul,from
Ahead of the Las Vegas Grand Prix,Chivas Regal comes together with Scuderia Ferrari HP in a multi-year partnership,with the iconic blended Scotch appointed \'Official Team Partner\'
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
